Devoted to the Pursuit of Clinical Excellence in Gastroenterology and Hepatology for Over 30 Years

  • Home

    • Privacy Policy
  • About

    • Membership
    • Board
    • Committees
  • 2022 GI Symposium

    • 2022 GI Sympo Sponsors
    • 2022 GI Symposium Slides
    • Accreditation Information
  • 2021-2022 Webinar Series

    • 2020-2021 Webinar Series
  • Newsletter

  • Resources

    • 2022 Liver Symposium Resource
    • 2021 GI Symposium
    • 2021 Liver Symposium
    • 2020 GI Symposium
    • 2019 Liver Symposium
    • 2019 GI Symposium
    • 2018 Post-AASLD
    • 2018 Post-DDW
    • 2017 Post-AASLD
    • 2017 Post-DDW
    • 2016 Post-AASLD
    • 2016 Post-DDW
    • 2015 Post-AASLD
    • 2015 Post-DDW
    • 2014 Post-AASLD
  • Plans & Pricing

  •  

    Use tab to navigate through the menu items.

    2017 Post-AASLD

    Frailty, Sarcopenia and Cirrhosis  Presented by Jennifer Lai, MD
    ​ Portal Hypertension   Presented by R. Todd Frederick, MD
    Recent and Future Changes in Liver Allograft Allocation  Presented by Brock A. Macdonald, MD
    Hepatocellular Carcinoma Presented by Francis Yao, MD
    Update in Viral Hepatitis       Presented by Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
    Cholestatic Liver Disease  Presented by Chris Bowlus, MD
    Emerging Therapies for NASH: What Can We Look Forward to and When? Presented by Paul Kwo, MD
    Noninvasive Measurement of Hepatic Fibrosis: It’s Here, are We Ready? Presented by Edward W. Holt

     E: ncscg@pacemedcom.com   

    • LinkedIn Social Icon

     The NCSCG Society is managed by Pace Medical Communications.